Literature DB >> 19008494

Reducing dietary fat from a meal increases the bioavailability of exogenous carbohydrate without altering plasma glucose concentration.

Nicolas D Knuth1, Cara R Shrivastava, Jeffrey F Horowitz.   

Abstract

The primary goal of this study was to determine the acute glycemic and endocrine responses to the reduction of fat content from a meal. On three separate occasions, nine overweight subjects (body mass index = 30 +/- 1 kg/m(2); 5 men, 4 women) consumed 1) a control meal ( approximately 800 kcal; 100 g of carbohydrate, 31 g of fat, and 30 g of protein), 2) a low-fat meal ( approximately 530 kcal; 100 g of carbohydrate, 1 g of fat, and 30 g of protein), or 3) a low-fat meal plus lipid infusion [same meal as low-fat meal, but the total energy provided was the same as control (800 kcal), with the "missing" fat ( approximately 30 g) provided via an intravenous lipid infusion]. All three meals contained [(13)C]glucose (3 mg/kg body wt) to assess the bioavailability of ingested glucose. During the 5-h period after each meal, we measured the recovery of [(13)C]glucose in plasma, plasma glucose, and insulin concentrations. We also measured plasma concentration of the gastrointestinal peptides: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and peptide YY(3-36) (PYY(3-36)). The recovery of the ingested [(13)C]glucose in the hour after ingestion was greater (P < 0.05) after the low-fat than after the control meal [area under the curve (AUC): 1,206 +/- 252 and 687 +/- 161 microM.h, respectively]. However, removing dietary fat from the meal did not affect the plasma concentration of glucose or insulin. Importantly, [(13)C]glucose recovery was not different during the low-fat and lipid infusion trials (AUC: 1,206 +/- 252 and 1,134 +/- 247 microM.h, respectively), indicating that the accelerated delivery of exogenous glucose found after removing fat from the meal is due exclusively to the reduction of fat in the gastrointestinal tract. In parallel with these findings, the reduction in fat calories from the meal reduced plasma concentration of GIP, GLP-1, and PYY(3-36). In summary, these data suggest that removing fat from the diet expedited exogenous glucose delivery into the systemic circulation and reduced the concentration of key gastrointestinal peptides, yet maintained plasma glucose concentration at control levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008494      PMCID: PMC2636944          DOI: 10.1152/japplphysiol.90404.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  40 in total

1.  A decrease in physical activity affects appetite, energy, and nutrient balance in lean men feeding ad libitum.

Authors:  R James Stubbs; Darren A Hughes; Alexandra M Johnstone; Graham W Horgan; Neil King; John E Blundell
Journal:  Am J Clin Nutr       Date:  2004-01       Impact factor: 7.045

2.  Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.

Authors:  Erik Näslund; N King; S Mansten; N Adner; J J Holst; M Gutniak; P M Hellström
Journal:  Br J Nutr       Date:  2004-03       Impact factor: 3.718

3.  Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies.

Authors:  A Flint; A Raben; J E Blundell; A Astrup
Journal:  Int J Obes Relat Metab Disord       Date:  2000-01

4.  Influence of dietary fat on postprandial glucose metabolism (exogenous and endogenous) using intrinsically (13)C-enriched durum wheat.

Authors:  S Normand; Y Khalfallah; C Louche-Pelissier; C Pachiaudi; J M Antoine; S Blanc; M Desage; J P Riou; M Laville
Journal:  Br J Nutr       Date:  2001-07       Impact factor: 3.718

5.  Measurements of cytoplasmic Ca2+ in islet cell clusters show that glucose rapidly recruits beta-cells and gradually increases the individual cell response.

Authors:  F C Jonkers; J C Henquin
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

Review 6.  The regulation of appetite.

Authors:  M Druce; S R Bloom
Journal:  Arch Dis Child       Date:  2006-02       Impact factor: 3.791

7.  Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice.

Authors:  R Burcelin; W Dolci; B Thorens
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

8.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

9.  Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia.

Authors:  Farhad Zangeneh; Rita Basu; Pankaj Shah; Puneet Arora; Michael Camilleri; Robert A Rizza
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-08       Impact factor: 4.310

10.  Quantitative kinetics of glucose appearance and disposal following a 13C-labelled starch-rich meal: comparison of male and female subjects.

Authors:  M Denise Robertson; Geoff Livesey; John C Mathers
Journal:  Br J Nutr       Date:  2002-06       Impact factor: 3.718

View more
  3 in total

1.  The ddY mouse: a model of postprandial hypertriglyceridemia in response to dietary fat.

Authors:  Tomomi Yamazaki; Kyoko Kishimoto; Osamu Ezaki
Journal:  J Lipid Res       Date:  2012-06-26       Impact factor: 5.922

Review 2.  Carbohydrate-restricted diets for obesity and related diseases: an update.

Authors:  Christy L Boling; Eric C Westman; William S Yancy
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

3.  Fish oil and olive oil can modify insulin resistance and plasma desacyl-ghrelin in rats.

Authors:  Atoosa Saidpour; Saleh Zahediasl; Masoud Kimiagar; Mohamadreza Vafa; Asghar Ghasemi; Alireza Abadi; Maryam Sadat Daneshpour; Maryam Zarkesh
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.